China Natl Uranium (001280.SZ)
Operating both domestically in China and across international markets, China National Uranium Co., Ltd. specializes in the extraction, refining, and commercial distribution of natural uranium. Its product portfolio extends to include monazite, uranium-molybdenum compounds, and other relevant offerings. This company, established in 1989 and based in Beijing, China, operates as a subordinate entity of China Nuclear Uranium Co., Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.26% | -5.16% | -13.56% | -24.57% | +6.59% | +18.96% | +6.59% | +6.59% | +6.59% | +6.59% | +6.59% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | +1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Uranium: +0.0%+15.1% ★ Q1'26: -41.6% (vs Q4'24)
-
EPS growth Uranium: +2.0%+11.3% ★
-
FCF margin FCF growth · Uranium: +20.0%-17.1% Q1'26: +18.1% (vs Q4'24)
-
EBIT margin Uranium: +0.0%+14.0% ★ Q1'26: +10.1% (vs Q4'24)
-
ROIC Uranium: -3.7%+12.8% ★ Q1'26: +6.9% (vs Q4'24)
-
Share dilution Uranium: -7.0%+1.4% ★
-
Debt / EBITDA Net debt/EBITDA · Uranium: -0.04×1.84× ★ Q1'26: 3.80× (vs Q4'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|
| Revenue |
19.89B
est: 18.66B (+6.6%)
|
19.34B
18.11B – 20.56B
+3.6% YoY
|
24.54B
21.76B – 27.32B
+26.9% YoY
|
| EBITDA |
3.29B
est: 3.18B (+3.6%)
|
3.29B
3.08B – 3.50B
+3.6% YoY
|
4.18B
3.71B – 4.65B
+26.9% YoY
|
| EBIT |
2.78B
est: 2.56B (+8.8%)
|
2.65B
2.48B – 2.82B
+3.6% YoY
|
3.36B
2.98B – 3.74B
+26.9% YoY
|
| Net Income |
1.65B
est: 1.68B (-2.2%)
|
1.98B
1.82B – 2.14B
+17.6% YoY
|
3.05B
2.80B – 3.30B
+54.2% YoY
|
| SGA |
278.57M
est: 646.79M (-56.9%)
|
670.33M
627.83M – 712.82M
+3.6% YoY
|
850.56M
754.14M – 946.98M
+26.9% YoY
|
| EPS |
0.89
est: 0.91 (-2.2%)
|
1.07
0.98 – 1.16
+17.6% YoY
|
1.65
1.51 – 1.79
+54.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-28 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-27 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-26 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-25 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-22 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-21 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-20 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-19 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-18 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-15 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-14 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-13 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-12 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-11 | B- | 2/5 | 2/5 | 3/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-08 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | B- | 3/5 | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | B- | 2/5 | 2/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | B- | 2/5 | 2/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | B- | 2/5 | 2/5 | 4/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | B- | 3/5 | 2/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | B- | 2/5 | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Da Wei Tang | Deputy General Manager | 1M | male |
| Feng Li | Deputy General Manager | 1M | male |
| Hui Wang | CFO, Chief Accountant, General Counsel & Board Secretary | — | male |
| Xue Bin Su | Chief Engineer | — | male |
| Yong Guo Xing | GM & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 001280.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
